Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Sep 8, 2018 at 7:10 AM EDT

Major Biopharma Catalysts on September’s FDA Calendar

Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food…

Trey Thoelcke | Sep 7, 2018 at 7:25 AM EDT

3 Buy-Rated Biotech Stocks Under $10 With Big Upside Potential

While they are more suited for aggressive accounts, these three biotech stocks trading under $10 that could provide investors with some…

Chris Lange | Sep 6, 2018 at 9:45 AM EDT

Why Arrowhead Pharma Shares Are Booming

Arrowhead Pharmaceuticals shares made a considerable gain early on Thursday after the firm announced data from its hepatitis B clinical…

Chris Lange | Sep 5, 2018 at 10:05 AM EDT

Why MannKind Shares More Than Doubled This Week

MannKind shares are continuing their rally from Tuesday when it was announced that United Therapeutics was licensing MannKind a dry…

Chris Lange | Sep 5, 2018 at 9:15 AM EDT

Why ProQR Therapeutics Shares Are Skyrocketing

ProQR Therapeutics shares made a massive gain early on Wednesday after the firm announced positive interim results from its Phase…

Douglas A. McIntyre | Sep 4, 2018 at 8:31 PM EDT

Over 1.4 Billion Adults Don’t Exercise Enough

New data from the WHO show that over 1.4 billion adults worldwide are at risk for disease because they do…

Chris Lange | Sep 4, 2018 at 9:50 AM EDT

BioCryst Pharmaceuticals Stock Retreats After HAE Study Results

BioCryst Pharmaceuticals shares fell on Tuesday after the company announced initial results from its hereditary angioedema trial.

Chris Lange | Aug 30, 2018 at 1:35 PM EDT

Sutro Biopharma Gears Up for IPO

Clinical-stage drug maker Sutro Biopharma has filed with the SEC regarding its initial public offering.

Paul Ausick | Aug 30, 2018 at 1:20 PM EDT

California Dialysis Legislation Pummels DaVita Shares

The California state Assembly on Wednesday approved a bill that limits the amount dialysis centers can charge patients. The legislation,…

Chris Lange | Aug 30, 2018 at 9:45 AM EDT

How Insys Is Winning With This FDA Update

InsysTherapeutics shares made a handy gain early on Thursday after the company announced an update from the FDA.

Chris Lange | Aug 29, 2018 at 12:15 PM EDT

Elanco Closes in on IPO

Eli Lilly spin-off Elanco Animal Health has amended its filing with the SEC regarding its initial public offering.

Jon C. Ogg | Aug 28, 2018 at 1:45 PM EDT

Are Some Cancer Treatments Becoming Too Expensive to Approve?

The topic of acceptable costs versus acceptable results is one that may never have a final conclusion in which everyone…

Chris Lange | Aug 28, 2018 at 11:55 AM EDT

Why Akcea and Ionis Are Getting Crushed

Akcea and Ionis were each crushed on Tuesday after the firms announced that they received a Complete Response Letter from…

Chris Lange | Aug 28, 2018 at 9:20 AM EDT

Why Affimed Shares More Than Doubled

Affimed shares more than doubled early on Tuesday after it was announced that the firm entered into a strategic collaboration…

Chris Lange | Aug 27, 2018 at 11:55 AM EDT

Ra Medical Closes in on IPO

Commercial-stage medical device company Ra Medical Systems has amended its filing with the SEC for its initial public offering.

1 … 121 122 123 124 125 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Major Biopharma Catalysts on September’s FDA Calendar

3 Buy-Rated Biotech Stocks Under $10 With Big Upside Potential

Why Arrowhead Pharma Shares Are Booming

Why MannKind Shares More Than Doubled This Week

Why ProQR Therapeutics Shares Are Skyrocketing

Over 1.4 Billion Adults Don’t Exercise Enough

BioCryst Pharmaceuticals Stock Retreats After HAE Study Results

Sutro Biopharma Gears Up for IPO

California Dialysis Legislation Pummels DaVita Shares

How Insys Is Winning With This FDA Update

Elanco Closes in on IPO

Are Some Cancer Treatments Becoming Too Expensive to Approve?

Why Akcea and Ionis Are Getting Crushed

Why Affimed Shares More Than Doubled

Ra Medical Closes in on IPO

Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Wall Street Analyst: SpaceX IPO Could Unleash Billions in New Public Offerings

Jeff Bezos’ New Venture Just Raised $12 Billion. He’s Betting AI Will Create a Physical Labor Shortage.

Retired Couple’s Three Pets Are Costing Them $14K a Year. What That Means for Retirement

Retired Couple's Three Pets Are Costing Them $14K a Year. What That Means for Retirement

A 65-Year-Old With $1.3M in a 401(k) Avoids the IRMAA Trap With This $50,000 Withdrawal Strategy

Wall Street Analyst: SpaceX IPO Could Unleash Billions in New Public Offerings

Jeff Bezos’ New Venture Just Raised $12 Billion. He’s Betting AI Will Create a Physical Labor Shortage.

Health and Healthcare Articles

All Health and Healthcare Articles

Major Biopharma Catalysts on September’s FDA Calendar

3 Buy-Rated Biotech Stocks Under $10 With Big Upside Potential

Why Arrowhead Pharma Shares Are Booming

Why MannKind Shares More Than Doubled This Week

Why ProQR Therapeutics Shares Are Skyrocketing

Over 1.4 Billion Adults Don’t Exercise Enough

BioCryst Pharmaceuticals Stock Retreats After HAE Study Results

Sutro Biopharma Gears Up for IPO

California Dialysis Legislation Pummels DaVita Shares

How Insys Is Winning With This FDA Update

Elanco Closes in on IPO

Are Some Cancer Treatments Becoming Too Expensive to Approve?

Why Akcea and Ionis Are Getting Crushed

Why Affimed Shares More Than Doubled

Ra Medical Closes in on IPO

Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Wall Street Analyst: SpaceX IPO Could Unleash Billions in New Public Offerings

Jeff Bezos’ New Venture Just Raised $12 Billion. He’s Betting AI Will Create a Physical Labor Shortage.

Retired Couple’s Three Pets Are Costing Them $14K a Year. What That Means for Retirement

Featured Reads

Retired Couple's Three Pets Are Costing Them $14K a Year. What That Means for Retirement

A 65-Year-Old With $1.3M in a 401(k) Avoids the IRMAA Trap With This $50,000 Withdrawal Strategy